Fee Schedule Strategy for Cosmetic Veneers: What Your Lab Costs Are Telling You

Veneer fee schedules tend to get set once, indexed to whatever the practice down the street charges, and revisited only when the lab bill spikes or a patient pushes back. That is not a strategy. That is a default. For a restorative practice running anywhere from 4 to 20 anterior veneer cases a month, the gap between a defended fee schedule and an inherited one shows up as five to seven points of operating margin per case, every case, for as long as the schedule stays in place.

This is written for general dentists and prosthodontists who want to think about veneer pricing the way the lab thinks about veneer fabrication: as a tiered product with real cost drivers, not a single line item.

Start With What the Case Actually Costs to Make

A single feldspathic veneer pressed on a refractory die is not the same product as a monolithic lithium disilicate veneer milled from a digital scan. The lab invoice may differ by 30 to 60 percent between those two, and the chair time differs by even more. Yet practices routinely list one veneer fee on the schedule and absorb the variance internally.

The first move is to map your last 24 months of veneer cases against three cost axes:

• Material and technique.Pressed lithium disilicate, layered feldspathic on refractory, layered zirconia, monolithic milled. Each carries a different lab fee and a different esthetic ceiling.
• Case complexity.A single peg lateral is not an 8-unit smile design. Shade-matching a single central next to a virgin contralateral is the hardest case in the practice and should be priced that way.
• Workflow.Full digital intraoral scan to milled provisional to final, versus PVS impression with stone model and hand-stacked porcelain. The digital workflow cuts your chair time on seat day by 20 to 40 minutes per arch in most reported workflows. That savings has a dollar value.

Once you have those three columns populated, the fee schedule writes itself. You are not pricing "a veneer." You are pricing a tier.

Build Three Tiers, Not One Fee

The practices holding the strongest cosmetic margins run a tiered veneer schedule, typically structured like this:

Tier 1: Standard cosmetic veneer.Monolithic or lightly characterized lithium disilicate, posterior to second bicuspid, used in smile-line extension cases where shade match is forgiving. Lab cost is the floor. Chair time is predictable. This is your volume tier.

Tier 2: Anterior esthetic veneer.Layered ceramic, cuspid to cuspid, where translucency, incisal effects, and adjacent-tooth blending matter. Lab cost runs 40 to 80 percent above Tier 1. Chair time at try-in is longer. Remake risk is real if the shade communication breaks down.

Tier 3: Complex anterior case.Single central next to a virgin tooth, full smile design with vertical dimension changes, or any case involving a refractory die technique or hand-stacked feldspathic on platinum foil. Lab cost can be double or triple Tier 1. These cases get a wax-up fee, a provisional fee, and a separate try-in appointment fee built into the quote.

When a patient is shopping a single peg lateral against a 10-unit smile design at the same per-unit price, the practice is losing money on the lateral or overcharging on the smile design. Probably both.

Make the Lab Invoice Part of the Treatment Plan Conversation

This is the move most practices skip, and it costs them. When a patient asks why the anterior case is priced higher than the posterior crown they had two years ago, the answer is not "because it is cosmetic." The answer is that the lab work on a layered feldspathic anterior involves a ceramist hand-building incisal translucency over three to five firings on a refractory die, and that work is invoiced to the practice at three times the cost of a monolithic posterior crown.

Patients respond to specificity. They do not respond to category labels.

This also means the lab partnership matters at the fee-schedule level, not just at the case level. A lab that ships the invoice with the technician's notes, the firing schedule used, and a photo of the case under the contralateral shade tab gives the practice usable material for the treatment plan conversation. A lab that ships a generic invoice with a line item that reads "veneer" does not.

Stop Subsidizing Remakes Inside the Standard Fee

If your remake rate on anterior veneers is running above 5 percent, you are baking the cost of the sixth case into the fees of the other five. That is a quiet 20 percent margin drag on a tier that already runs tight.

The two levers here are upstream, not downstream:

1. Shade communication.Photographs with a polarizing filter, the shade tab held in the same plane as the tooth, and a written note describing value, chroma, and any characterizations. Verbal shade calls over the phone are the single largest cause of remakes on anterior cases.
2. Provisional approval.On Tier 3 cases, the patient should approve the provisional in writing before the final ceramic is fabricated. This is not a legal protection. It is a workflow that catches shape and contour issues before they become remake invoices.

A lab running a remake rate under 2.5 percent on anterior cases is doing it through case planning and communication discipline, not through better porcelain. The practice gets to share that benefit only if the schedule reflects it.

Index the Schedule Annually, Not When the Lab Bill Hurts

The last piece is procedural. Veneer fee schedules should get a formal review every 12 months, indexed against three inputs: lab cost increases, chair time per case (measured, not estimated), and the local market for comparable cosmetic work. Practices that wait until the lab raises prices to look at the schedule end up making reactive 8 to 12 percent jumps that patients notice. Practices that index 3 to 5 percent annually on a calendar do not have that conversation.

The schedule is a document. Treat it like one.

What This Looks Like in Practice

For a restorative practice doing 10 anterior veneer cases a month, moving from a flat veneer fee to a three-tier schedule with documented lab cost mapping typically recovers 6 to 9 percent of cosmetic revenue inside the first quarter. That is not from raising prices on patients. That is from pricing complex cases at their actual cost and stopping the cross-subsidy from simple cases.

The lab cannot set the fee schedule. But the lab invoice, read carefully, is the cleanest signal the practice gets about where the cosmetic margin is leaking. Use it.